Microglial cells are the pathologic sensor of the brain, and any pathologic event triggers microglial activation, which involves migration of these cells to a lesion site. Employing different migration assays, we show that ligands for toll-like receptor (TLR) 2 stimulate random motility, while TLR7 ligands are chemoattractants. The subtype specificity of the TLR ligands was verified by using different TLRdeficient (TLRKO) mouse lines. PI3K and Rac inhibition impairs both TLR2-and TLR7-stimulated microglial migration. In contrast, Akt phosphorylation is only required for the TLR2-, but not for the TLR7-stimulated pathway. Interestingly, P2Y12 receptor signaling is involved in the TLR2 activation-induced microglial migration but not TLR7. Furthermore, TLR7 mRNA expression is down-regulated by TLR2 and TLR7 activation. We conclude that TLRs control the migratory behavior of microglia in a distinct manner.
Introduction
Microglia are considered as the immune cells of the central nervous system (CNS) and are activated in any type of pathologic context (David and Kroner, 2011; Hanisch and Kettenmann, 2007) . Various mediators including cytokines, chemokines, and also agonists of toll-like receptors (TLRs) trigger microglial activation (Farber and Kettenmann, 2006; Rosenberger et al., 2014) . Microglia express all known members of the TLR family identified to date (Hanke and Kielian, 2011) . They constitutively express TLR2 (Kielian et al., 2002; Laflamme et al., 2003; Olson and Miller, 2004; Rasley et al., 2002; Zekki et al., 2002) and are capable of recognizing numerous TLR2 ligands, including lipoproteins and the synthetic lipoprotein analogue Pam3CSK4 (synthetic triacylated lipoprotein), as well as Pam2CSK4 (synthetic diacylated lipoprotein) and LTA (lipoteichoic acid) (Chien et al., 2005; Ebert et al., 2005; Jung et al., 2005; Kielian et al., 2002; Olson and Miller, 2004; Omueti et al., 2005) . We have recently found that TLR2 plays an important role for mediating interaction between microglia and glioma cells. Versican is an endogenous ligand released from glioma, which activates TLR2 on microglia and converts these cells into a pro-tumorigenic phenotype (Hambardzumyan et al., 2016) . Recent studies demonstrated that TLR7, which recognizes viral single-stranded RNA, can play an important role in both activation of innate immune responses and pathogenesis of autoimmune diseases (Butchi et al., 2010; Desire et al., 2005; Lewis et al., 2008; Town et al., 2009 ). These immune responses are not only elicited by GU-rich viral single-stranded RNA but also by synthetic chemicals that include imidazoquinoline compounds such as imiquimod and resiquimod as well as guanosine analogues such as loxoribine (Diebold et al., 2004; Heil et al., 2004; Hemmi et al., 2002) . TLR signaling does not only lead to the release of neurotoxic molecules such as inflammatory cytokines and reactive oxygen species (Boje and Arora, 1992; Lehnardt et al., 2008) , but also influences other cellular functions such as proliferation and cell migration. In pancreatic cells, activation of TLR7 has been reported to inhibit proliferation and migration (Zou et al., 2015) , while TLR2 agonists stimulate human neutrophil migration via activation of mitogenactivated protein kinases (Aomatsu et al., 2008) . In microglia, motility is controlled by a variety of substances such as ATP (Davalos et al., 2005) , which is also a chemoattractant for microglial cells (Honda et al., 2001) , bradykinin (Ifuku et al., 2007) , galanin (Ifuku et al., 2011), or morphine (Horvath and DeLeo, 2009; Takayama and Ueda, 2005) . The direct effect of TLR agonists on microglial migration has not been investigated so far.
In the present study, we investigated the TLR agonist-induced increase in microglial migration and its underlying signaling http://dx.doi.org/10.1016/j.bbi.2016.08.003 0889-1591/Ó 2016 Elsevier Inc. All rights reserved.
